Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$17,224,593
in 1 filing
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. EcoR1 Capital, LLC +$17.2M Director 1 filing
  2. RENTON HOLLINGS −$249K Director sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2017-07-26 Avalon Ventures VII L P 10% owner Sale −37,040 $24.35 $902K 0
2017-02-24 Schoeneck James A Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 Schmid John P. Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 RENTON HOLLINGS Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 Lydon Nicholas Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 Gallagher Carol Giltner Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 Topper James N Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-02-24 Piscitelli Dominic Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2017-02-24 MOYLE MATTHEW Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2017-02-24 Londei Marco Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2017-02-24 Suria Hamza President, CEO Grant or award · Employee Stock Option (right to buy) +225,000 225,000
2017-02-02 Frazier Healthcare VII, L.P. 10% owner Option exercise +117,235 $4.55 $533K 2,345,612
2017-02-02 Frazier Healthcare VII, L.P. 10% owner Option exercise · Warrants −117,235 0
2017-02-02 Frazier Healthcare V, LP 10% owner Option exercise +117,235 $4.55 $533K 2,345,612
2017-02-02 Frazier Healthcare V, LP 10% owner Option exercise · Warrants −117,235 0
2017-01-31 Novo A/S 10% owner Conversion +1,428,571 1,428,571
2017-01-31 Novo A/S 10% owner Conversion +486,820 1,915,391
2017-01-31 Novo A/S 10% owner Conversion +312,986 2,228,377
2017-01-31 Novo A/S 10% owner Conversion +673,454 2,901,831
2017-01-31 Novo A/S 10% owner Option exercise +81,673 2,983,504

Page 33 of 36 · 714 trades